Cancer Genome Atlas Project Marks “Beginning Of A New Era,” Zerhouni Says
This article was originally published in The Pink Sheet Daily
The pilot project is intended to identify and characterize genetic mutations associated with cancer.
You may also be interested in...
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor